Advertisement

Ads Placeholder
Loading...

Neuphoria Therapeutics Inc.

NEUP•NASDAQ
Healthcare
Medical - Pharmaceuticals
$4.41
$0.29(7.04%)
U.S. Market opens in 5h 42m

Neuphoria Therapeutics Inc. (NEUP) Stock Overview

Explore Neuphoria Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.3M
P/E Ratio-0.05
EPS (TTM)$-0.69
ROE-15.38%
Fundamental Analysis

AI Price Forecasts

1 Month$4.33
3 Months$6.46
1 Year Target$3.71

NEUP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Neuphoria Therapeutics Inc. (NEUP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 8.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.04%
5-Day Change
7.56%
1-Month Change
1.38%
3-Month Change
15.45%
6-Month Change
-77.34%
Year-to-Date (YTD) Change
15.45%
1-Year Change
-22.08%
3-Year Change
-83.74%
5-Year Change
-97.51%
All-Time (Max) Change
-97.51%

Contact Information

http://www.neuphoriatx.com
NaN
100 Summit Dr, Burlington, NaN, NaN

Company Facts

80 Employees
IPO DateDec 16, 2021
CountryUS
Actively Trading

Frequently Asked Questions